Crotonylation of MCM6 enhances chemotherapeutics sensitivity of breast cancer via inducing DNA replication stress
Cell Proliferation · 2025
DOI: 10.1111/cpr.13759 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, 2025. Verfasst von Haoyun Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Lanzhou University, Gansu, China. Hauptthemen laut MEDLINE: Breast Neoplasms, DNA Replication, Minichromosome Maintenance Complex Component 6, Antineoplastic Agents. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Open fund project of NHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumors.
Abstract (Originalsprache)
Breast cancer is associated with high morbidity and mortality, which are closely influenced by protein post‐translational modifications (PTMs). Lysine crotonylation (Kcr) serves as a newly identified PTM type that plays a role in various biological processes; however, its involvement in breast cancer progression remains unclear. Minichromosome maintenance 6 (MCM6) is a critical component of DNA replication and has been previous confirmed to exhibit a significant role in tumorigenesis. Despite this, a comprehensive analysis of MCM6, particularly regarding its modifications in breast cancer is lacking. In this study, we found MCM6 is upregulated in breast invasive carcinoma (BRCA) and is associated with poorer overall survival by regulating the DNA damage repair mechanisms. Furthermore, MCM6‐knockdown resulted in decreased cell proliferation and inhibited the DNA replication, leading to DNA replication stress and sustained DNA damage, thereby enhancing the chemotherapeutic sensitivity of breast cancer. Additionally, SIRT7‐mediated crotonylation of MCM6 at K599 (MCM6‐K599cr) was significantly upregulated in response to DNA replication stress, primarily due to the disassemebly of the MCM2‐7 complex and regulated by RNF8‐mediated ubiquitination. Concurrently, kaempferol, which acts as a regulator of SIRT7, was found to enhance the Kcr level of MCM6, reducing tumour weight, particular when combined with paclitaxel, highlighting its potential chemotherapeutic target for BRCA therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Lanzhou University, Gansu, China.
- NHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Lanzhou, Gansu Province, China.
ORCID-Profile: Haoyun Song
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Open fund project of NHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumors
- Young scientific and technological talent innovation project of Lanzhou
Zitieren
APA
Song, H., Guo, Z., Xie, K., Liu, X., Yang, X., Shen, R., & Wang, D. (2025). Crotonylation of MCM6 enhances chemotherapeutics sensitivity of breast cancer via inducing DNA replication stress. Cell Proliferation. https://doi.org/10.1111/cpr.13759
Vancouver
Song H, Guo Z, Xie K, Liu X, Yang X, Shen R, et al. Crotonylation of MCM6 enhances chemotherapeutics sensitivity of breast cancer via inducing DNA replication stress. Cell Proliferation. 2025. doi:10.1111/cpr.13759
BibTeX
@article{Song2025,
author = {Song, Haoyun and Guo, Zhao and Xie, Kun and Liu, Xiangwen and Yang, Xuguang and Shen, Rong and Wang, Degui},
title = {Crotonylation of MCM6 enhances chemotherapeutics sensitivity of breast cancer via inducing DNA replication stress},
journal = {Cell Proliferation},
year = {2025},
doi = {10.1111/cpr.13759}
}
EUVIMED